Amplification of hypoxia-inducible factor 1α gene in prostate cancer

被引:47
作者
Saramäki, OR
Savinainen, KJ
Nupponen, NN
Bratt, O
Visakorpi, T [1 ]
机构
[1] Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Tampere, Finland
[3] Helsingborg Hosp, Dept Surg, Helsingborg, Sweden
基金
芬兰科学院;
关键词
D O I
10.1016/S0165-4608(01)00396-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that regulates the expression of genes associated with adaptation to reduced oxygen pressure. Increased expression of HIF-1 alpha gene (NIF1A) has been found in the majority of prostate carcinomas. In addition, the PC-3 prostate cancer cell line has been shown to express the gene even under normoxic conditions. By comparative genomic hybridization (CGH), we have earlier shown that the PC-3 cell line contains a high-level amplification in the chromosomal region harboring the HIF1A gene. Here, we first fine mapped the gene to locus 14q23 by fluorescence in situ hybridization (FISH). The gene was then shown to be highly amplified in the PC-3 cell line. Subsequently, the copy number of the HIF1A gene was studied in 5 other prostate cancer cell lines (LNCaP, DU-145, NCI-H660, Tsu-Pr, JCA-1) and in 117 prostate tumors representing both hormone-dependent and -refractory disease as well as primary and metastatic lesions. No high-level amplifications of the HIF1A gene were found. Additional copies of the gene were seen in all of the cell lines and in 36% of the tumors. There was no association between the tumor type and the copy number alterations of the gene. In conclusion, high-level amplification of the HIF1A gene may explain the overexpression of the gene in the PC-3 prostate cancer cell line. However, such high-level amplification seems to be very rare in prostate cancer. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:31 / 34
页数:4
相关论文
共 21 条
  • [1] ONCOGENE AMPLIFICATION IN TUMOR-CELLS
    ALITALO, K
    SCHWAB, M
    [J]. ADVANCES IN CANCER RESEARCH, 1986, 47 : 235 - 281
  • [2] [Anonymous], 1980, Histological typing of prostate tumours / F. K. Mostofi, in collaboration with I. Sesterhenn
  • [3] Positional cloning of ZNF217 and NABC1:: Genes amplified at 20q13.2 and overexpressed in breast carcinoma
    Collins, C
    Rommens, JM
    Kowbel, D
    Godfrey, T
    Tanner, M
    Hwang, S
    Polikoff, D
    Nonet, G
    Cochran, J
    Myambo, K
    Jay, KE
    Froula, J
    Cloutier, T
    Kuo, WL
    Yaswen, P
    Dairkee, S
    Giovanola, J
    Hutchinson, GB
    Isola, J
    Kallioniemi, OP
    Palazzolo, M
    Martin, C
    Ericsson, C
    Pinkel, D
    Albertson, D
    Li, WB
    Gray, JW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8703 - 8708
  • [4] Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation
    Dachs, GU
    Tozer, GM
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (13) : 1649 - 1660
  • [5] Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
  • [6] Höckel M, 1999, CANCER RES, V59, P4525
  • [7] Höckel M, 1998, INT J CANCER, V79, P365
  • [8] IMPROVED TECHNIQUE FOR ANALYSIS OF FORMALIN-FIXED, PARAFFIN-EMBEDDED TUMORS BY FLUORESCENCE IN-SITU HYBRIDIZATION
    HYYTINEN, E
    VISAKORPI, T
    KALLIONIEMI, A
    KALLIONIEMI, OP
    ISOLA, JJ
    [J]. CYTOMETRY, 1994, 16 (02): : 93 - 99
  • [9] Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O-2 tension
    Jiang, BH
    Semenza, GL
    Bauer, C
    Marti, HH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 271 (04): : C1172 - C1180
  • [10] Activation of hypoxia-inducible factor 1 alpha: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor
    Kallio, PJ
    Pongratz, I
    Gradin, K
    McGuire, J
    Poellinger, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) : 5667 - 5672